Innovent Biologics, Inc. Operating Cash Flow for the year ending December 31, 2024: USD 176.27 M

Innovent Biologics, Inc. Operating Cash Flow is USD 176.27 M for the year ending December 31, 2024, a 746.68% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Innovent Biologics, Inc. Operating Cash Flow for the year ending December 31, 2023 was USD 20.82 M, a -107.49% change year over year.
  • Innovent Biologics, Inc. Operating Cash Flow for the year ending December 31, 2022 was USD -278.05 M, a -12.75% change year over year.
  • Innovent Biologics, Inc. Operating Cash Flow for the year ending December 31, 2021 was USD -318.67 M, a 576.04% change year over year.
  • Innovent Biologics, Inc. Operating Cash Flow for the year ending December 31, 2020 was USD -47.14 M, a -80.28% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities